APO RESEARCH · REPORT
BCI and EEG
This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
Product & engineering
Understand the product.
This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.
Selected research
Industry Research
BCI and EEG Industry Research Report 2026
Market perspective
This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.
Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.
Read the full market overview
Report Scope
This report quantifies the global BCI and EEG market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to BCI and EEG.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
BCI and EEG Market by Company
Medtronic
Natus Medical
Nihon Kohden
NeuroPace Inc
Mindmaze SA
G.TEC
BrainCo
InteraXon
Brain Products GmbH
EGI
Blackrock Microsystems LLC
Emotiv Inc
Micromed
ANT Neuro B.V
Compumedics Limited
NeuroSky, Inc.
Artinis Medical Systems BV
Cadwell
Advanced Brain Monitoring
NCC Medical
SYMTOP
Neuroelectrics
BCI and EEG Segment by Type
Hardware
Software and Service
BCI and EEG Segment by Application
Medical
Consumer
BCI and EEG Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCI and EEG market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of BCI and EEG and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCI and EEG.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of BCI and EEG companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hardware
- Software and Service
Applications
- Medical
- Consumer
Companies covered
- Medtronic
- Natus Medical
- Nihon Kohden
- NeuroPace Inc
- Mindmaze SA
- G.TEC
- BrainCo
- InteraXon
- Brain Products GmbH
- EGI
- Blackrock Microsystems LLC
- Emotiv Inc
- Micromed
- ANT Neuro B.V
- Compumedics Limited
- NeuroSky, Inc.
- Artinis Medical Systems BV
- Cadwell
- Advanced Brain Monitoring
- NCC Medical
- SYMTOP
- Neuroelectrics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 BCI and EEG by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hardware
- 2.2.3 Software and Service
- 2.3 BCI and EEG by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical
- 2.3.3 Consumer
- 2.4 Assumptions and Limitations
3 BCI and EEG Breakdown Data by Type
- 3.1 Global BCI and EEG Historic Market Size by Type (2021-2026)
- 3.2 Global BCI and EEG Forecasted Market Size by Type (2027-2032)
4 BCI and EEG Breakdown Data by Application
- 4.1 Global BCI and EEG Historic Market Size by Application (2021-2026)
- 4.2 Global BCI and EEG Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global BCI and EEG Market Perspective (2021-2032)
- 5.2 Global BCI and EEG Growth Trends by Region
- 5.2.1 Global BCI and EEG Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 BCI and EEG Historic Market Size by Region (2021-2026)
- 5.2.3 BCI and EEG Forecasted Market Size by Region (2027-2032)
- 5.3 BCI and EEG Market Dynamics
- 5.3.1 BCI and EEG Industry Trends
- 5.3.2 BCI and EEG Market Drivers
- 5.3.3 BCI and EEG Market Challenges
- 5.3.4 BCI and EEG Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top BCI and EEG Players by Revenue
- 6.1.1 Global Top BCI and EEG Players by Revenue (2021-2026)
- 6.1.2 Global BCI and EEG Revenue Market Share by Players (2021-2026)
- 6.2 Global BCI and EEG Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of BCI and EEG Head Office and Area Served
- 6.4 Global BCI and EEG Players, Product Type & Application
- 6.5 Global BCI and EEG Manufacturers Established Date
- 6.6 Global BCI and EEG Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America BCI and EEG Market Size (2021-2032)
- 7.2 North America BCI and EEG Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America BCI and EEG Market Size by Country (2021-2026)
- 7.4 North America BCI and EEG Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe BCI and EEG Market Size (2021-2032)
- 8.2 Europe BCI and EEG Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe BCI and EEG Market Size by Country (2021-2026)
- 8.4 Europe BCI and EEG Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific BCI and EEG Market Size (2021-2032)
- 9.2 Asia-Pacific BCI and EEG Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific BCI and EEG Market Size by Country (2021-2026)
- 9.4 Asia-Pacific BCI and EEG Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America BCI and EEG Market Size (2021-2032)
- 10.2 South America BCI and EEG Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America BCI and EEG Market Size by Country (2021-2026)
- 10.4 South America BCI and EEG Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa BCI and EEG Market Size (2021-2032)
- 11.2 Middle East & Africa BCI and EEG Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa BCI and EEG Market Size by Country (2021-2026)
- 11.4 Middle East & Africa BCI and EEG Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medtronic
- 12.1.1 Medtronic Company Information
- 12.1.2 Medtronic Business Overview
- 12.1.3 Medtronic Revenue in BCI and EEG Business (2021-2026)
- 12.1.4 Medtronic BCI and EEG Product Portfolio
- 12.1.5 Medtronic Recent Developments
- 12.2 Natus Medical
- 12.2.1 Natus Medical Company Information
- 12.2.2 Natus Medical Business Overview
- 12.2.3 Natus Medical Revenue in BCI and EEG Business (2021-2026)
- 12.2.4 Natus Medical BCI and EEG Product Portfolio
- 12.2.5 Natus Medical Recent Developments
- 12.3 Nihon Kohden
- 12.3.1 Nihon Kohden Company Information
- 12.3.2 Nihon Kohden Business Overview
- 12.3.3 Nihon Kohden Revenue in BCI and EEG Business (2021-2026)
- 12.3.4 Nihon Kohden BCI and EEG Product Portfolio
- 12.3.5 Nihon Kohden Recent Developments
- 12.4 NeuroPace Inc
- 12.4.1 NeuroPace Inc Company Information
- 12.4.2 NeuroPace Inc Business Overview
- 12.4.3 NeuroPace Inc Revenue in BCI and EEG Business (2021-2026)
- 12.4.4 NeuroPace Inc BCI and EEG Product Portfolio
- 12.4.5 NeuroPace Inc Recent Developments
- 12.5 Mindmaze SA
- 12.5.1 Mindmaze SA Company Information
- 12.5.2 Mindmaze SA Business Overview
- 12.5.3 Mindmaze SA Revenue in BCI and EEG Business (2021-2026)
- 12.5.4 Mindmaze SA BCI and EEG Product Portfolio
- 12.5.5 Mindmaze SA Recent Developments
- 12.6 G.TEC
- 12.6.1 G.TEC Company Information
- 12.6.2 G.TEC Business Overview
- 12.6.3 G.TEC Revenue in BCI and EEG Business (2021-2026)
- 12.6.4 G.TEC BCI and EEG Product Portfolio
- 12.6.5 G.TEC Recent Developments
- 12.7 BrainCo
- 12.7.1 BrainCo Company Information
- 12.7.2 BrainCo Business Overview
- 12.7.3 BrainCo Revenue in BCI and EEG Business (2021-2026)
- 12.7.4 BrainCo BCI and EEG Product Portfolio
- 12.7.5 BrainCo Recent Developments
- 12.8 InteraXon
- 12.8.1 InteraXon Company Information
- 12.8.2 InteraXon Business Overview
- 12.8.3 InteraXon Revenue in BCI and EEG Business (2021-2026)
- 12.8.4 InteraXon BCI and EEG Product Portfolio
- 12.8.5 InteraXon Recent Developments
- 12.9 Brain Products GmbH
- 12.9.1 Brain Products GmbH Company Information
- 12.9.2 Brain Products GmbH Business Overview
- 12.9.3 Brain Products GmbH Revenue in BCI and EEG Business (2021-2026)
- 12.9.4 Brain Products GmbH BCI and EEG Product Portfolio
- 12.9.5 Brain Products GmbH Recent Developments
- 12.10 EGI
- 12.10.1 EGI Company Information
- 12.10.2 EGI Business Overview
- 12.10.3 EGI Revenue in BCI and EEG Business (2021-2026)
- 12.10.4 EGI BCI and EEG Product Portfolio
- 12.10.5 EGI Recent Developments
- 12.11 Blackrock Microsystems LLC
- 12.11.1 Blackrock Microsystems LLC Company Information
- 12.11.2 Blackrock Microsystems LLC Business Overview
- 12.11.3 Blackrock Microsystems LLC Revenue in BCI and EEG Business (2021-2026)
- 12.11.4 Blackrock Microsystems LLC BCI and EEG Product Portfolio
- 12.11.5 Blackrock Microsystems LLC Recent Developments
- 12.12 Emotiv Inc
- 12.12.1 Emotiv Inc Company Information
- 12.12.2 Emotiv Inc Business Overview
- 12.12.3 Emotiv Inc Revenue in BCI and EEG Business (2021-2026)
- 12.12.4 Emotiv Inc BCI and EEG Product Portfolio
- 12.12.5 Emotiv Inc Recent Developments
- 12.13 Micromed
- 12.13.1 Micromed Company Information
- 12.13.2 Micromed Business Overview
- 12.13.3 Micromed Revenue in BCI and EEG Business (2021-2026)
- 12.13.4 Micromed BCI and EEG Product Portfolio
- 12.13.5 Micromed Recent Developments
- 12.14 ANT Neuro B.V
- 12.14.1 ANT Neuro B.V Company Information
- 12.14.2 ANT Neuro B.V Business Overview
- 12.14.3 ANT Neuro B.V Revenue in BCI and EEG Business (2021-2026)
- 12.14.4 ANT Neuro B.V BCI and EEG Product Portfolio
- 12.14.5 ANT Neuro B.V Recent Developments
- 12.15 Compumedics Limited
- 12.15.1 Compumedics Limited Company Information
- 12.15.2 Compumedics Limited Business Overview
- 12.15.3 Compumedics Limited Revenue in BCI and EEG Business (2021-2026)
- 12.15.4 Compumedics Limited BCI and EEG Product Portfolio
- 12.15.5 Compumedics Limited Recent Developments
- 12.16 NeuroSky, Inc.
- 12.16.1 NeuroSky, Inc. Company Information
- 12.16.2 NeuroSky, Inc. Business Overview
- 12.16.3 NeuroSky, Inc. Revenue in BCI and EEG Business (2021-2026)
- 12.16.4 NeuroSky, Inc. BCI and EEG Product Portfolio
- 12.16.5 NeuroSky, Inc. Recent Developments
- 12.17 Artinis Medical Systems BV
- 12.17.1 Artinis Medical Systems BV Company Information
- 12.17.2 Artinis Medical Systems BV Business Overview
- 12.17.3 Artinis Medical Systems BV Revenue in BCI and EEG Business (2021-2026)
- 12.17.4 Artinis Medical Systems BV BCI and EEG Product Portfolio
- 12.17.5 Artinis Medical Systems BV Recent Developments
- 12.18 Cadwell
- 12.18.1 Cadwell Company Information
- 12.18.2 Cadwell Business Overview
- 12.18.3 Cadwell Revenue in BCI and EEG Business (2021-2026)
- 12.18.4 Cadwell BCI and EEG Product Portfolio
- 12.18.5 Cadwell Recent Developments
- 12.19 Advanced Brain Monitoring
- 12.19.1 Advanced Brain Monitoring Company Information
- 12.19.2 Advanced Brain Monitoring Business Overview
- 12.19.3 Advanced Brain Monitoring Revenue in BCI and EEG Business (2021-2026)
- 12.19.4 Advanced Brain Monitoring BCI and EEG Product Portfolio
- 12.19.5 Advanced Brain Monitoring Recent Developments
- 12.20 NCC Medical
- 12.20.1 NCC Medical Company Information
- 12.20.2 NCC Medical Business Overview
- 12.20.3 NCC Medical Revenue in BCI and EEG Business (2021-2026)
- 12.20.4 NCC Medical BCI and EEG Product Portfolio
- 12.20.5 NCC Medical Recent Developments
- 12.21 SYMTOP
- 12.21.1 SYMTOP Company Information
- 12.21.2 SYMTOP Business Overview
- 12.21.3 SYMTOP Revenue in BCI and EEG Business (2021-2026)
- 12.21.4 SYMTOP BCI and EEG Product Portfolio
- 12.21.5 SYMTOP Recent Developments
- 12.22 Neuroelectrics
- 12.22.1 Neuroelectrics Company Information
- 12.22.2 Neuroelectrics Business Overview
- 12.22.3 Neuroelectrics Revenue in BCI and EEG Business (2021-2026)
- 12.22.4 Neuroelectrics BCI and EEG Product Portfolio
- 12.22.5 Neuroelectrics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst